Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Zhihuang Tongfeng decoction ameliorates gouty arthritis via inhibition of NLRP3 inflammasome in rats

Xiong Wang1, Jun Wu2, Li Ma, Jie Ping2, Dan Luo2, Yuan Wang2, Yong-gang Chen1, Jin-hu Wu1, Xiang-you Li2

1Department of Pharmacy; 2Department of Nephrology, Tongren Hospital of Wuhan University (The Third Hospital of Wuhan), Wuhan 430060; 3College of Basic Medicine, Wuhan University, Wuhan 430071, Hubei, China.

For correspondence:-  Xiang-you Li   Email: lixiangyou1974@126.com   Tel:+862768894852

Accepted: 21 November 2019        Published: 31 December 2019

Citation: Wang X, Wu J, Ma L, Ping J, Luo D, Wang Y, et al. Zhihuang Tongfeng decoction ameliorates gouty arthritis via inhibition of NLRP3 inflammasome in rats. Trop J Pharm Res 2019; 18(12):2577-2582 doi: 10.4314/tjpr.v18i12.17

© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect and mechanism of action of traditional Chinese medicine, Zhihuang Tongfeng decoction (ZTD), on gouty arthritis in rats.
Methods: Monosodium urate (MSU) crystal was injected into the ankle joint of rats to establish an animal model of gouty arthritis. ZTD (4.8, 9.6 and 19.2 g/kg) was administered to the rats. The walking behavior of the rats was observed daily and the gait score computed. Histopathologic severity was scored using three parameters, viz, synovial inflammation, synovial hyperplasia and cartilage surface erosion. The levels of IL-1β and TNF-α in lavage fluid of articular cavities were measured by ELISA. The synovial tissues of the joint of all the rats were obtained and NLRP3 inflammasome analysed by Western blot.
Results: The results revealed that compared with control rats, 19.2 g/kg dose of ZTD lowered the owestry disability index of the rats significantly from 2.3 ± 0.4 to 0.9 ± 0.3 (p < 0.05). Pathomorphology analysis showed that ZTD attenuated the swelling of toes and the infiltration of inflammatory cells in synovium significantly (p < 0.05). Further, ZTD decreased the IL-1β (p < 0.05) and TNF-α levels (p < 0.05) at all doses, and inhibited NLRP3 (p < 0.01), caspase-1 (p < 0.01), ASC (p < 0.01), IL-1β (p < 0.01) and IL-18 (p < 0.01) protein expressions in the lavage fluid of articular cavities in MSU crystal-treated rats.
Conclusion: The results indicate that ZTD ameliorates gouty arthritis in rats by inhibiting NLRP3 inflammasome, and thus can potentially be developed into a new drug for the treatment of gouty arthritis.

Keywords: Zhihuang Tongfeng decoction, Gouty arthritis, NLRP3 inflammasome

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates